Stokes J. et al, (2018), Health Policy
Preference-based measures to obtain health state utility values for use in economic evaluations with child-based populations: a review and UK-based focus group assessment of patient and parent choices.
Wolstenholme JL. et al, (2018), Qual Life Res, 27, 1769 - 1780
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS).
Reed SD. et al, (2018), Diabetes Obes Metab, 20, 1732 - 1739
The melanoma genomics managing your risk study: A protocol for a randomized controlled trial evaluating the impact of personal genomic risk information on skin cancer prevention behaviors.
Smit AK. et al, (2018), Contemp Clin Trials, 70, 106 - 116
Comparison of statistical approaches for analyzing incomplete longitudinal patient-reported outcome data in randomized controlled trials
Rombach I. et al, (2018), Patient Related Outcome Measures
Strengthening the evidence-base of integrated care for people with multi-morbidity in Europe using Multi-Criteria Decision Analysis (MCDA)
Rutten-van Molken M. et al, (2018), BMC Health Services Research
Alcohol Screening and Brief Intervention in Police Custody Suites: Pilot Cluster Randomised Controlled Trial (AcCePT)
Addison M. et al, (2018), Alcohol And Alcoholism
Thorn JC. et al, (2018), Value Health, 21, 640 - 649
A cluster randomized trial of strategies to increase uptake amongst young women invited for their first cervical screen: The STRATEGIC trial.
Kitchener H. et al, (2018), J Med Screen, 25, 88 - 98
Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.
Morrell L. et al, (2018), BMC Health Serv Res, 18
Task shifting between physicians and nurses in acute care hospitals: Cross-sectional study in nine countries
Maier CB. et al, (2018), Human Resources for Health, 16
Leal J. et al, (2018), PharmacoEconomics
Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial.
Wang K. et al, (2018), BMJ open, 8, e021144 - e021144
ARE WHOLE EXOME AND WHOLE GENOME SEQUENCING APPROACHES COSTEFFECTIVE? A SYSTEMATIC REVIEW OF THE LITERATURE
Schwarze K. et al, (2018), VALUE IN HEALTH, 21, S100 - S100
Cost-effectiveness of cognitive behavioural therapy for sleep disorder added to usual care in patients with schizophrenia: the BEST study
Tsiachristas A. et al, (2018), BJPsych Open
Women’s preferences for alternative financial incentive schemes for breastfeeding: A discrete choice experiment
BECKER F. et al, (2018), PLoS ONE
Associations between preoperative Oxford hip and knee scores and costs and quality of life of patients undergoing primary total joint replacement in the NHS England: an observational study.
Eibich P. et al, (2018), BMJ open, 8, e019477 - e019477